Voisin Consulting Life Sciences post icon
Press release

VCLS obtains ISO/IEC 27001 certification

Post thumbnail VCLS obtains ISO/IEC 27001 certification

April 17th, 2023, Paris, France

Voisin Consulting Life Sciences (VCLS), a leading global HealthTech solution provider, offering end-to-end solutions from preclinical to post-launch, today is proud to announce that it has successfully obtained ISO/IEC 27001 certification from BSI for the whole Voisin Consulting group for Regulatory Strategy, Pharmacovigilance, Publishing effectively April 12th 2023.

ISO/IEC 27001 is the world’s best-known standard, one the most stringent, to manage information security. This credential came after the implementation of a secure and effective information security management system that respects all the best practices and principles enshrined in this International Standard. It is a tool for risk management, for cyber-resilience and operational excellence.

“We are thrilled to obtain this respected certification”, said Dr. Emmanuelle Voisin, Founder & CEO of VCLS. “It is a recognition of VCLS’s high standard of Information Security System and Quality Management System, as well as the level of excellence of our team every day to clients and partners worldwide.”

“We take the security of our system seriously, it’s everyone’s responsibility at VCLS. We will continue to adhere to the standards and continually improve upon them to meet our clients’ expectations and to be more competitive.” said Sébastien Schweitzer, Director of Information Technologies at VCLS.

 

About VCLS

 

VCLS provides end-to-end HealthTech solutions, to support biotechnology, pharmaceutical and MedTech manufacturers throughout their product development. From early-stage development through to post launch, VCLS assists innovators by designing product development strategies, conducting clinical trials that optimize clinical development to drive commercial success.

The integrated solutions encompass clinical research, vigilance, regulatory strategy & submissions, Chemistry Manufacturing & Control (CMC) and market access. With offices in the US, France, UK, Switzerland, Denmark, Madagascar, India and China, VCLS serves a broad range of developers and investors in HealthTech.

 

For more information, visit www.voisinconsulting.com

Media contact:

Zhengxi Danard

Marketing Director, VCLS

+33 1 41 31 89 90

danard@voisinconsutling.com